Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Improved Outcomes for Patients Treated with Lantus® and Apidra® Regimen Compared with Sliding Scale Insulin
Yahoo/BusinessWire
Sat, 06/26/10 - 09:31 am
Lantus
Apidra
Sanofi
diabetes
Diabetes drug makers gain ahead of conference
MarketWatch
Sat, 06/26/10 - 09:13 am
Arca pharmaceutical index
MannKind
Amylin
Molecular Insight
diabetes
Lilly CEO: Diabetes: We’ve Come Far — But Have a Long Way to Go
CNBC
Fri, 06/25/10 - 11:24 am
Eli Lilly
Pharma CEOs
diabetes
John Lechleiter
Sanofi-Aventis signs license deal with Metabolex
Marketwatch
Fri, 06/25/10 - 10:13 am
Sanofi
licensing
Metabolex
diabetes
Drug Pipeline Pulse Check: Roche’s Stumble Boosts Amylin
Seeking Alpha
Thu, 06/24/10 - 10:11 am
Roche
Amylin
diabetes
taspoglutide
Sanofi-Aventis Is `on Track' to Meet Diabetes Sales Targets, Chancel Says
Bloomberg
Thu, 06/24/10 - 08:41 am
Sanofi
diabetes
Lantus
Victoza
Novo Nordisk
STMicroelectronics and Debiotech Debut Disposable Insulin Jewel Pump at ADA Congress
Wed, 06/23/10 - 11:17 am
STMicroelectronics
Debiotech
Jewel Pump
insulin pumps
diabetes
Diabetes And Obesity Options Percolate At JNJ, Novo
Forbes
Wed, 06/23/10 - 09:07 am
obesity
Novo Nordisk
diabetes
JNJ
Ortho-McNeil-Janssen
J&J cuts 2 deals for diabetes treatment
Yahoo/AP
Tue, 06/22/10 - 10:33 am
JNJ
diabetes
Diamyd Medical
partnerships
Metabolex
J&J Pays $45M for Diabetes Treatment
TheStreet.com
Tue, 06/22/10 - 09:47 am
JNJ
diabetes
Diamyd Medical
partnerships
San Diego's Neurocrine Biosciences Scores Second Big Deal in Two Days
Motley Fool
Fri, 06/18/10 - 11:46 am
Neurocrine
Abbott Laboratories
diabetes
Boehringer Ingelheim
endometriosis
Amylin, Alkermes gain ground on Roche drug delay
Yahoo/AP
Fri, 06/18/10 - 11:28 am
Roche
Amylin
Alkermes
diabetes
taspoglutide
Sanofi Drops Most in Month on Concern Diabetes Drug May Raise Cancer Risk
Bloomberg
Fri, 06/18/10 - 09:28 am
Lantus
diabetes
Sanofi
Roche Expects Delay to Taspoglutide on Safety Concern
Bloomberg
Fri, 06/18/10 - 07:40 am
Roche
taspoglutide
diabetes
MannKind Bear Analysts Strike Again
Seeking Alpha
Wed, 06/16/10 - 08:23 am
MannKind
Afrezza
Eli Lilly
inhaled insulin
diabetes
Amylin Drug Fails To Beat Generic
Forbes
Tue, 06/15/10 - 12:36 pm
generics
Amylin
metformin
diabetes
Bydureon
Byetta
Eli Lilly
A Booster Shot for Sluggish Times
Mon, 06/14/10 - 02:59 pm
Becton Dickinson
diabetes
Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes
Yahoo
Mon, 06/14/10 - 12:41 pm
IMIDIA
diabetes
AstraZeneca
Roche
Sanofi
Boehringer Ingelheim
Eli Lilly
Novartis
Novo Nordisk
Another Step Back For MannKind?
Pharmalot
Fri, 06/11/10 - 10:18 am
MannKind
inhaled insulin
diabetes
Afrezza
Glaxo upped at Barclays, Avandia concerns overdone
Marketwatch
Fri, 06/11/10 - 07:59 am
Avandia
diabetes
GSK
Pages
« first
‹ previous
…
101
102
103
104
105
106
107
108
109
…
next ›
last »